Vaishali Pharma Ltd.
Snapshot View

86.80 +0.45 ▲0.5%

17 August 2022, 10:28:53 AM
Volume: 11,602

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vaishalipharma.com
Market Cap 91.07 Cr.
Enterprise Value(EV) 110.47 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 4.48 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 19.28 Trailing Twelve Months Ending 2022-06
Industry PE 32.22 Trailing Twelve Months Ending 2022-06
Book Value / Share 26.42 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.27 Calculated using Price: 86.35
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.05 Cr. 10,546,213 Shares
FaceValue 10
Company Profile
The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For its export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it has successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.52%
1 Week
-0.40%
1 Month
+5.40%
3 Month
+8.16%
6 Month
+63.62%
1 Year
+96.60%
2 Year
+105.20%
5 Year
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 26.24 10.28 5.12 -0.94 19.80 6.49 3.40 0.15 4.78
Return on Capital Employed (%) 13.59 19.23 14.04 12.80 16.18 12.75 9.80 6.89 10.33
Return on Assets (%) 1.44 0.59 0.33 -0.06 1.51 1.47 1.08 0.05 1.38

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 3 3 3 3 4 21 21 21 22 26
Non Curr. Liab. 3 3 8 5 3 3 5 4 4 3
Curr. Liab. 43 47 34 42 37 41 42 40 59 52
Minority Int.
Equity & Liab. 49 53 46 49 45 64 69 66 86 81
Non Curr. Assets 1 2 2 2 5 5 6 5 5 5
Curr. Assets 48 52 44 47 40 59 63 61 81 76
Misc. Exp. not W/O
Total Assets 49 53 46 49 45 64 69 66 86 81

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 119 121 95 67 64 68 75 60 54 78
Other Income 0 1 4 3 1 2 2 2 2 2
Total Income 119 122 99 70 65 69 77 62 56 79
Total Expenditure -117 -118 -95 -66 -61 -65 -73 -59 -51 -70
PBIDT 2 3 4 4 4 4 4 3 4 9
Interest -1 -3 -3 -3 -3 -3 -3 -3 -3 -2
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 0 -2
Exceptional Items
PAT 1 0 0 0 1 1 1 0 1 5
Adjusted EPS 8 4 2 0 1 1 1 0 1 4

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 4 -7 -4 5 0 -9 4 3 2
Cash Fr. Inv. 0 0 2 3 1 1 0 0 0
Cash Fr. Finan. -4 6 2 -8 -1 9 -4 -3 -2
Net Change 0 -1 0 0 0 0 0 0
Cash & Cash Eqvt 2 1 1 1 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 64.03 63.88 63.84 63.81 59.21 56.31 56.31 26.74 26.74
Public 35.98 36.13 36.16 36.19 40.80 43.69 43.69 73.25 73.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 27 Jul 2022
Newspaper Advertisements
Vaishali Pharma Limited has informed the Exchange about Newspaper Advertisements
Tue, 26 Jul 2022
Newspaper Advertisements
Vaishali Pharma Limited has informed the Exchange about Newspaper Advertisements
Tue, 26 Jul 2022
Outcome of Board Meeting
Vaishali Pharma Limited has informed the Exchange about Board Meeting held on 25-Jul-2022 to consider financial statements for the period ended June 2022

Technical Scans View Details >>

Tue, 16 Aug 2022
Closing Below Previous Low Closing Below Previous Low
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
High Increase 1 Year High Increase 1 Year
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 920.80 +0.7%
Divi's Laboratories Ltd. 99,072.87 3,767.85 +1.0%
Cipla Ltd. 83,487.41 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. 53,261.16 1,565.55 -0.5%
Piramal Enterprises Ltd. 45,983.34 1,981.05 +2.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-06 33.44 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,981.05 +2.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-06 3.87 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,981.05 +2.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,981.05 +2.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,981.05 +2.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,981.05 +2.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,981.05 +2.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +0.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,767.85 +1.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,029.75 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,315.15 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,325.20 -0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,565.55 -0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,981.05 +2.8%

FAQ's On Vaishali Pharma Ltd.

Can I Buy Vaishali Pharma Shares now?

What is the Share Price of Vaishali Pharma?

What is the Relative Strength Index (RSI) Value of Vaishali Pharma?

What is the Market Capital (MCAP) of Vaishali Pharma?

What are the key metrics to analyse Vaishali Pharma?

What is the Price Performance of Vaishali Pharma?